SponsoredBlogPost_21

Now Available On-Demand: CEC Oncology Presents “Navigating Novel Terrain in Neurofibromatosis Type 1: An Interactive Road Map for the Oncology Nurse in the Era of Targeted Therapy”

Designed, developed, and delivered by CEC Oncology Neurofibromatosis type 1 (NF1) is a complex condition of immense clinical gravity, and though the traditional management paradigm has long been circumscribed by a limited and ineffectual trimodal combination of surgery, radiation, and surveillance, the recent emergence of trial data in support of targeted medical therapies is renewing […]

Read more
SponsoredBlogPost_21

BD’s PortReady™ Program Supports the Therapeutic Apheresis Community with PowerFlowTM Implantable Apheresis IV Port Resources

Brought to you by BD Launched in 2017, the PowerFlowTM Implantable Apheresis IV Port is a high-flow, power-injectable1 port designed and indicated specifically for therapeutic apheresis. Because of its newness to the market, BD has taken steps to ensure that educational tools are ready and available to patients, nurses, and other healthcare professionals. We believe […]

Read more
SponsoredBlogPost_21

Learn How to Manage the Challenges of MDS

Brought to you by The Aplastic Anemia and MDS International Foundation The Aplastic Anemia and MDS International Foundation invites you to participate in our ONS Congress satellite symposium, The Spectrum of MDS:  Disease Management and Patient Education in the ONS Congress virtual platform. MDS is challenging to diagnose, but the evolving genomic and immunologic landscape […]

Read more
Attendee at computer

3,200 Nurses Came Together Virtually to Spark Change, Now What?

Jen Krause, Director of National Conferences and Meetings More than 3,200 oncology nurses came together virtually for the 46th Annual ONS Congress™ to learn, connect, and share. From fast-paced live Q&As with invited speakers to heated competition in the Virtual Challenge, attendees made (and are still making) the most of their time in the digital space.   This year’s […]

Read more
SponsoredBlogPost_21

“Advocating for your Patient: Real-World Biosimilar Experience,” presented on behalf of Fresenius Kabi

Brought to you by Fresenius Kabi Healthcare providers and patients can expect the same efficacy and safety from a biosimilar as from the originator biologic, as biosimilars and originators are highly similar in terms of structure, function, and quality. Biosimilars also have the potential to reshape the biologic landscape and can improve patient costs and […]

Read more